1-7 of 7
Kazuhide Nakamura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B

Shinji Takagi, Yoshinori Ishikawa, Akio Mizutani, Shinji Iwasaki, Satoru Matsumoto, Yusuke Kamada, Toshiyuki Nomura, Kazuhide Nakamura
Journal: Cancer Research
Cancer Res (2017) 77 (17): 4652–4662.
https://doi.org/10.1158/0008-5472.CAN-16-3502
Published: 31 August 2017
View articletitled, LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B
Open the PDF for LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B in another window
Includes: Supplementary data
Journal Articles

Abstract 26: Panitumumab interacts with TAS-102 leading to combinational anti-cancer effects by blocking EGFR-mediated tumor response to trifluridine

Kazuhide Nakamura, Yuji Baba, Toshiya Tamura, Yoshihiko Satoh, Masamitsu Gotou, Hiroshi Sawada, Shunsuke Ebara, Kazunori Shibuya, Jumpei Soeda
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 26.
https://doi.org/10.1158/1538-7445.AM2017-26
Published: 01 July 2017
View articletitled, Abstract 26: Panitumumab interacts with TAS-102 leading to combinational anti-cancer effects by blocking EGFR-mediated tumor response to trifluridine
Journal Articles

KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties

Kazuhide Nakamura, Eri Taguchi, Toru Miura, Atsushi Yamamoto, Kazumi Takahashi, Francis Bichat, Nicolas Guilbaud, Kazumasa Hasegawa, Kazuo Kubo, Yasunari Fujiwara, Rika Suzuki, Kinya Kubo, Masabumi Shibuya, Toshiyuki Isae
Journal: Cancer Research
Cancer Res (2006) 66 (18): 9134–9142.
https://doi.org/10.1158/0008-5472.CAN-05-4290
Published: 18 September 2006
View articletitled, KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties
Open the PDF for KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties in another window
Includes: Supplementary data
Journal Articles

The efficacy of KRN951, a novel VEGF receptor tyrosine kinase inhibitor, in intraperitoneal disseminated tumor models

Eri Taguchi, Kazuhide Nakamura, Toru Miura, Masabumi Shibuya, Toshiyuki Isoe
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1373.
Published: 01 May 2005
View articletitled, The efficacy of KRN951, a novel VEGF receptor tyrosine kinase inhibitor, in intraperitoneal disseminated tumor models
Journal Articles

The VEGF receptor inhibitor KRN951 decreases vascular permeability in tumors and inhibits tumor growth: an analysis using dynamic contrast-enhanced magnetic resonance imaging

Kazuhide Nakamura, Eri Taguchi, Toru Miura, Francis Bichat, Nathalie Just, Olivier Duchamp, Paul Walker, Nicolas Guilbaud, Toshiyuki Isoe
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1375.
Published: 01 May 2005
View articletitled, The VEGF receptor inhibitor KRN951 decreases vascular permeability in tumors and inhibits tumor growth: an analysis using dynamic contrast-enhanced magnetic resonance imaging
Journal Articles

In vitro selectivity and potency of KRN951, a novel inhibitor of VEGF receptor tyrosine kinases

Kazuhide Nakamura, Eri Taguchi, Kazumi Takahashi, Masaru Kamishohara, Toru Miura, Masabumi Shibuya, Toshiyuki Isoe
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 594.
Published: 01 April 2004
View articletitled, In vitro selectivity and potency of KRN951, a novel inhibitor of VEGF receptor tyrosine kinases
Journal Articles

A novel orally active inhibitor of VEGF receptor tyrosine kinases KRN951: Anti-angiogenic and anti-tumor activity against human solid tumors

Eri Taguchi, Kazuhide Nakamura, Kazumi Takahasi, Masaru Kamishohara, Toru Miura, Masabumi Shibuya, Toshiyuki Isoe
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 595.
Published: 01 April 2004
View articletitled, A novel orally active inhibitor of VEGF receptor tyrosine kinases KRN951: Anti-angiogenic and anti-tumor activity against human solid tumors